Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.220
-0.020 (-0.47%)
Feb 17, 2026, 3:10 PM EST - Market open
Cytek Biosciences Analyst Ratings
Total Analysts
5
Consensus Rating
Hold
Price Target
$5.70
Upside
+35.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $4 → $5 | Strong Buy | Maintains | $4 → $5 | +18.48% | Jan 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $7.5 | Buy | Maintains | $8 → $7.5 | +77.73% | Nov 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +65.88% | May 28, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $3.5 → $3 | Strong Sell | Maintains | $3.5 → $3 | -28.91% | May 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $6 | Buy | Reiterates | $6 | +42.18% | Mar 19, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +89.57% | Mar 4, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $5.25 → $4.5 | Strong Sell | Maintains | $5.25 → $4.5 | +6.64% | Mar 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4.5 → $5.25 | Strong Sell | Maintains | $4.5 → $5.25 | +24.41% | Feb 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Strong Sell Downgrades $7 → $4.5 | Strong Buy → Strong Sell | Downgrades | $7 → $4.5 | +6.64% | Jan 31, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $8.5 | Buy | Maintains | $8 → $8.5 | +101.42% | Nov 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +89.57% | Aug 13, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +65.88% | Aug 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $8.5 | Buy | Maintains | $10 → $8.5 | +101.42% | May 13, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +89.57% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +136.97% | Mar 6, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +136.97% | Feb 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.